LeonaBio, Inc. (LONA): Cash & Equivalents
$69.28M
As of 2025-12-31
$32.32M
As of 2026-06-30
-10.3%
3-year compound annual growth
+2.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $69.28M | +43.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $48.44M | -46.5% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $90.58M | -5.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $95.97M | -13.2% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $110.54M | +82.3% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $60.62M | n/m | 2022-03-28, Balance as of period end |
| 2019-12-31 | $2.06M | n/a | 2021-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| LeonaBio, Inc. (LONA) | 2025-12-31 | $69.28M | +43.0% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $10.74M | -2.8% |
| IRulya Therapeutics Inc. (IRLA) | 2025-12-31 | $5.81M | -6.5% |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | $18.30M | -50.5% |
| Surrozen, Inc. (SRZN) | 2025-12-31 | $89.25M | +158.2% |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $14.68M | -25.7% |
| Anavex Life Sciences Corp. (AVXL) | 2025-09-30 | $102.58M | -22.4% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $66.05M | +36.0% |
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | $8.69M | -6.5% |
Compare LONA, ATYR, IRLA, ALGS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗